ChatGPT and Generative AI: What Are the Implications of This Technology?
Articles & stories

ChatGPT and Generative AI: What Are the Implications of This Technology?

OpenAI’s ChatGPT is reported to have seen growth rates that suggest it is the fastest-growing tool/app in history, registering 100 million users by January 2023 after its launch in November 2022. Our global research report is focused on ChatGPT, adjacent AI use cases that may emerge by industry/sector, the AI hardware supply chain that will scale it, and finally the companies that are most likely to benefit on the back of sharply increasing AI model deployments.

We view OpenAI’s technology innovations, the progression of generative/conversational AI, and Microsoft’s Bing AI broadly transformative and predominantly a productivity, cost-cutting, and efficiency tool versus a revenue-generating tool today as it pertains to most industries. In this report we detail over 100 examples of use cases of both ChatGPT, and key AI uses cases beyond ChatGPT across 13 industries. However, despite ChatGPT (and other recent AI innovations) being embraced by businesses and organizations globally already, there are risks posed by ChatGPT and some limitations of the GPT Large Language Models (LLMs) have surfaced, likely requiring regulation considering the impact it has on society.

We therefore believe rules and regulations are needed for AI development and ChatGPT specifically considering the potential impact it has on society. Although there are no current regulations on ChatGPT yet, relevant discussions have been going on regarding how to make sure the impact from the recent developments are responsible and controlled.

@Sami Badri
@Randy Abrams
@Chris Caso
@Shannon Cross

Related Articles

  1. Therapeutic Journeys in Diabetes: A focus on GLP-1 drugs

    Therapeutic Journeys in Diabetes: A focus on GLP-1 drugs
    The proportion of patients starting GLP or GIP-GLP treatment without prior diabetes treatment has risen substantially in recent quarters. Our analysis accords well with historical Novo Nordisk's Wegovy in '21 and Eli Lilly's Mounjaro in '22 commentary and brings the data forward to look at 1Q 2023.

  2. No changes in our European utility convictions

    No changes in our European utility convictions
    The European utility sector has seen little differentiation in performance across the past three months, with a 9% increase in absolute terms and a 5% outperformance versus the MSCI Europe. Energy prices have fallen, but windfall taxes and price caps introduced in 2022 could limit near-term negative earnings per share (EPS) momentum. But the sector has already de-rated to reflect this.

  3. What could Europe’s green subsidy plan look like?

    What could Europe’s green subsidy plan look like?
    With the European Green Deal announced in 2019, Europe was the first to declare its ambition to be a climate-neutral continent. COVID-19 and the complexities of European green subsidies meant that considerable funds are still to be deployed. In the meantime, the US Inflation Reduction Act (announced in July 2022) has received significant attention owing to the simplicity of the mechanism and the potential for a more favourable policy to attract investment into the country. This policy move has prompted the European Commission to respond with the proposed Green Deal Industrial Plan (“GDIP”) to mobilise various forms of state aid for the green transition.